Related Experiment Videos
Elevated plasma thymosin-alpha1 levels in lung cancer patients
1Department of Surgery II, Nagoya City University Medical School, Japan.
Summary
Plasma thymosin-alpha1 levels may indicate lung cancer prognosis. Higher levels in lung cancer patients suggest poorer survival, warranting further investigation into thymosin-alpha1
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Prothymosin-alpha is a precursor to thymosin-alpha1.
- Thymosin-alpha1 may influence cell proliferation.
- Plasma thymosin-alpha1 levels might indicate tumor cell proliferation extent.
Purpose of the Study:
- To measure plasma and tissue levels of thymosin-alpha1 in lung cancer patients.
- To investigate the correlation between thymosin-alpha1 levels and lung cancer characteristics.
- To assess thymosin-alpha1 as a prognostic marker in lung cancer.
Main Methods:
- Utilized a new sandwich immunoradiometric assay for thymosin-alpha1.
- Measured thymosin-alpha1 in plasma and tissue samples from 131 lung cancer patients.
- Compared levels between lung cancer patients and healthy individuals.
Main Results:
- Lung cancer patients exhibited higher mean plasma thymosin-alpha1 levels than controls (P < 0.001).
- Thymosin-alpha1 levels did not correlate with cancer stage, subtype, or post-resection changes.
- Patients with normal thymosin-alpha1 levels showed significantly better survival than those with higher levels (P = 0.04).
Conclusions:
- Plasma thymosin-alpha1 may serve as a prognostic marker for lung cancer.
- Further research is needed to elucidate the specific role of thymosin-alpha1 in lung cancer.